Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
These include the peptides quantity, the target concentration required for the study, and the precision needed for laboratory measurements
(1) SDT fatty rats given certified diet-experimental animal diet 2 (CE-2), a standard chow provided from CLEA (CLEA, Tokyo, Japan) (DKD-vehicle), (2) SDT fatty rats given CE-2 containing empagliflozin (EMPA)(30 mg/kg, Boehringer-Ingelheim, Germany)for 12 weeks (DKD-EMPA), and (3) SDT fatty rats given empagliflozin diet for first 6 weeks and switched to CE-2 containing EMPA and linagliptin (LINA) (3 mg/kg, Boehringer-Ingelheim, Germany) (DKD-EMPA + LINA)
May 23, 2018
Feasibility of exenatide, a GLP-1R agonist, for treating cocaine use disorder: a case series study
Formulation Stability and Compatibility FAQ 1
US$ 22.92
US$ 24.10
US$ 22.42
US$ 28.70
US$ 27.35
